Click To Tune In Here…. https://www.youtube.com/watch?v=6FY2GwsV_CM
EXCLUSIVE: Pasithea Administers First IV Ketamine Infusion Therapy In Depression Patients
Pasithea Therapeutics Corp's (NASDAQ: KTTA) wholly-owned subsidiary, Pasithea Clinics, has administered intravenous (IV) ketamine therapy to its first patients with treatment-resistant depression.
Pasithea Clinics commenced IV ketamine infusion therapy in Knightsbridge, London.